{"date":"2026-06-28","count":3,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6712-2026-06-28-1541-p72f19","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-06-28","time":"15:41:47","subject":"本公司新藥CAR001第一期臨床試驗完成，並獲衛生福利部食品藥物管理署(TFDA)同意開啟Phase Ⅱa臨床試驗收案","clause":"第10款","fact_date":"2026-06-28","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-06-28 15:41，「本公司新藥CAR001第一期臨床試驗完成，並獲衛生福利部食品藥物管理署(TFDA)同意開啟Phase Ⅱa臨床試驗收案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-06-28-1020-16y073i","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-06-28","time":"10:20:30","subject":"公告本公司獨立董事對審計委員會決議事項表示反對意見。","clause":"第44款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-06-28 10:20，「公告本公司獨立董事對審計委員會決議事項表示反對意見。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-06-28-1018-11d4fwr","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-06-28","time":"10:18:37","subject":"公告本公司審計委員會選任代表人為公司對董事提起訴訟。","clause":"第53款","fact_date":"2026-06-26","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-06-28 10:18，「公告本公司審計委員會選任代表人為公司對董事提起訴訟。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}